Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy

Lior H. Katz; Abigail Fraser; Leonard Leibovici; Ran Tur-Kaspa; Hadar Goldvaser

doi:10.1002/14651858.cd005264.pub3

Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy

Lior H. Katz
, Abigail Fraser
, Leonard Leibovici
, Ran Tur-Kaspa
, Hadar Goldvaser

Tel Aviv University
University of Bristol
Rabin Medical Center Israel

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Article number	CD005264
Journal	Cochrane Database of Systematic Reviews
Volume	2019
Issue number	9
DOIs	https://doi.org/10.1002/14651858.cd005264.pub3
State	Published - 12 Sep 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/14651858.cd005264.pub3

Cite this

@article{813b182cddf74789a78fa84d50fe6df9,

title = "Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy",

author = "Katz, \{Lior H.\} and Abigail Fraser and Leonard Leibovici and Ran Tur-Kaspa and Hadar Goldvaser",

year = "2019",

month = sep,

day = "12",

doi = "10.1002/14651858.cd005264.pub3",

language = "אנגלית",

volume = "2019",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy

AU - Katz, Lior H.

AU - Fraser, Abigail

AU - Leibovici, Leonard

AU - Tur-Kaspa, Ran

AU - Goldvaser, Hadar

PY - 2019/9/12

Y1 - 2019/9/12

UR - https://www.scopus.com/pages/publications/85072724957

U2 - 10.1002/14651858.cd005264.pub3

DO - 10.1002/14651858.cd005264.pub3

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:85072724957

SN - 1465-1858

VL - 2019

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD005264

ER -

Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy

UN SDGs

Access to Document

Other files and links

Cite this